Kamila Brielle Pantoja Vasconcelos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kamila Brielle Pantoja Vasconcelos has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Pablício Pereira Cardoso
Programa de Pós-Graduação em Recursos Naturais da Amazônia, Universidade Federal do Oeste do Pará—UFOPA, Santarém 68040-255, PA, Brazil
6 shared publications - Silvia Katrine Rabelo da Silva
Programa de Pós-Graduação em Recursos Naturais da Amazônia, Universidade Federal do Oeste do Pará—UFOPA, Santarém 68040-255, PA, Brazil
6 shared publications - Rafael Silva Cardoso
Instituto de saúde coletiva, Universidade Federal do Oeste do Pará—UFOPA, Santarém 68040-255, PA, Brazil
5 shared publications - Zandleme Birino de Oliveira
Graduate Program in Biodiversity and Biotechnology – BIONORTE Network Santarém Brazil
4 shared publications - Amanda de Lima Silva Mumberger
Graduate Program in Biodiversity and Biotechnology – BIONORTE Network Santarém Brazil
3 shared publications - Gabriel Padilla
Universidade de São Paulo
2 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Natural Colorants From Amazonian Plants: Bioactive Potential and Sustainable Extraction Techniques—A Review
This review synthesized and compared extraction methodologies for anthocyanins, carotenoids, betalains, and chlorophylls from Amazonian species, highlighting extraction yield, compound stability, bioactivity preservation, and industrial feasibility of conventional and green approaches. A systematized search was conducted in Google Scholar, ScienceDirect, PubMed, SciELO, ACS Publications, and Scopus, covering publications from 2010 to 2025. Eligible studies included original articles, systematic reviews, and laboratory assays reporting extraction techniques with analytical identification confirmed by high‐performance liquid chromatography (HPLC) or spectrophotometry and quantitative yield data. In total, 36 records of Amazonian species were analyzed: anthocyanins ( n = 12), carotenoids ( n = 9), betalains ( n = 6), and chlorophylls ( n = 10), in addition to 18 comparative studies involving other plant matrices. açaí ( Euterpe oleracea ), bacaba ( Oenocarpus bacaba ), and camu‐camu ( Myrciaria dubia ) were the main sources of anthocyanins, whereas buriti ( Mauritia flexuosa ) and tucumã ( Astrocaryum vulgare ) accounted for most carotenoid reports. Betalains were primarily described in pitaya and facheiro, and chlorophylls in tree leaves. Deep eutectic solvents (DES), natural deep eutectic solvents (NADES), and supercritical carbon dioxide (CO 2 ), combined with ultrasound‐assisted extraction (UAE), microwave‐assisted extraction (MAE), and pulsed electric fields (PEF), showed superior performance compared with conventional methods. DES containing choline chloride achieved 41.3 mg/100 g of carotenoids versus 11.5 mg/100 g with ethanol, being up to 3.5 times more efficient. The PEF–ethanol combination recovered more than 80% of total carotenoids. Green solvents associated with emerging technologies represent technically viable and environmentally superior routes, while native betalains and chlorophylls remain underexplored, representing a priority research gap.
- 14 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Open AccessNatural Colorants From Amazonian Plants: Bioactive Potential and Sustainable Extraction Techniques—A Review
This review synthesized and compared extraction methodologies for anthocyanins, carotenoids, betalains, and chlorophylls from Amazonian species, highlighting extraction yield, compound stability, bioactivity preservation, and industrial feasibility of conventional and green approaches. A systematized search was conducted in Google Scholar, ScienceDirect, PubMed, SciELO, ACS Publications, and Scopus, covering publications from 2010 to 2025. Eligible studies included original articles, systematic reviews, and laboratory assays reporting extraction techniques with analytical identification confirmed by high‐performance liquid chromatography (HPLC) or spectrophotometry and quantitative yield data. In total, 36 records of Amazonian species were analyzed: anthocyanins ( n = 12), carotenoids ( n = 9), betalains ( n = 6), and chlorophylls ( n = 10), in addition to 18 comparative studies involving other plant matrices. açaí ( Euterpe oleracea ), bacaba ( Oenocarpus bacaba ), and camu‐camu ( Myrciaria dubia ) were the main sources of anthocyanins, whereas buriti ( Mauritia flexuosa ) and tucumã ( Astrocaryum vulgare ) accounted for most carotenoid reports. Betalains were primarily described in pitaya and facheiro, and chlorophylls in tree leaves. Deep eutectic solvents (DES), natural deep eutectic solvents (NADES), and supercritical carbon dioxide (CO 2 ), combined with ultrasound‐assisted extraction (UAE), microwave‐assisted extraction (MAE), and pulsed electric fields (PEF), showed superior performance compared with conventional methods. DES containing choline chloride achieved 41.3 mg/100 g of carotenoids versus 11.5 mg/100 g with ethanol, being up to 3.5 times more efficient. The PEF–ethanol combination recovered more than 80% of total carotenoids. Green solvents associated with emerging technologies represent technically viable and environmentally superior routes, while native betalains and chlorophylls remain underexplored, representing a priority research gap.
- Open Access
- 30 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (10) , 983
Streptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. In this study, a bibliometric analysis of the scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus was performed, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors (“Streptomyces” AND “Staphylococcus aureus”), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (21.7%), Pharmacology and Pharmacy (16.8%), and Biotechnology and Applied Microbiology (16.1%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research on Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance.
- 30 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (10) , 983
Open AccessStreptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. In this study, a bibliometric analysis of the scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus was performed, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors (“Streptomyces” AND “Staphylococcus aureus”), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (21.7%), Pharmacology and Pharmacy (16.8%), and Biotechnology and Applied Microbiology (16.1%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research on Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance.
- Open Access
- 26 June 2025
- Published by MDPI AG in Preprints.org
Streptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. This study conducted a bibliometric analysis of scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors ("Streptomyces" AND "Staphylococcus aureus"), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3,705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (27.67%), Pharmacology and Pharmacy (21.51%), and Biotechnology and Applied Microbiology (20.50%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research into Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance.
- 26 June 2025
- Published by MDPI AG in Preprints.org
Open AccessStreptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. This study conducted a bibliometric analysis of scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors ("Streptomyces" AND "Staphylococcus aureus"), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3,705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (27.67%), Pharmacology and Pharmacy (21.51%), and Biotechnology and Applied Microbiology (20.50%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research into Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance.
- Open Access
- 12 June 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2138
BIOPROSPECÇÃO DE ACTINOBACTÉRIA ISOLADA DE ROCHAS CARBONÁTICAS NA AMAZÔNIA
Bioprospecting seeks to improve products and processes from natural resources. Despite the biotechnological potential of Actinobacteria, the Amazon remains underexplored in this context. The present study investigated the potential of a strain of Actinobacterium isolated from carbonate rocks in Amazonia region. For this purpose, a biochemical characterization was carried out, obtaining antitumor secondary metabolites and cytotoxic testing of Actinobacterians. The results showed that the bacterial strain PML5, exhibits promising for biotechnological and pharmacological applications. The morphology of the culture is consistent with the typical morphological profile of bacteria of genus Streptomyces. The biochemical characterization revealed the production of lipase, esterase and L-asparaginase enzymes, suggesting a diversified and adaptive metabolic potential of the strain. The antagonism test highlighted its remarkable antimicrobial activity against gram-positive and gram-negative pathogens. Most notably, the crude extract of the strain demonstrated 96% inhibition of cell growth in lineage of human colorectal cancer cells, suggesting the presence of bioactive compounds with anticancer potential. Therefore, this study contributes to the microbial biodiversity in the Amazon region, and also opens new perspectives, for the bioprospecting of Actinobacteria as sources of bioactive compounds and therapeutic agents.
- 12 June 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2138
Open AccessBIOPROSPECÇÃO DE ACTINOBACTÉRIA ISOLADA DE ROCHAS CARBONÁTICAS NA AMAZÔNIA
Bioprospecting seeks to improve products and processes from natural resources. Despite the biotechnological potential of Actinobacteria, the Amazon remains underexplored in this context. The present study investigated the potential of a strain of Actinobacterium isolated from carbonate rocks in Amazonia region. For this purpose, a biochemical characterization was carried out, obtaining antitumor secondary metabolites and cytotoxic testing of Actinobacterians. The results showed that the bacterial strain PML5, exhibits promising for biotechnological and pharmacological applications. The morphology of the culture is consistent with the typical morphological profile of bacteria of genus Streptomyces. The biochemical characterization revealed the production of lipase, esterase and L-asparaginase enzymes, suggesting a diversified and adaptive metabolic potential of the strain. The antagonism test highlighted its remarkable antimicrobial activity against gram-positive and gram-negative pathogens. Most notably, the crude extract of the strain demonstrated 96% inhibition of cell growth in lineage of human colorectal cancer cells, suggesting the presence of bioactive compounds with anticancer potential. Therefore, this study contributes to the microbial biodiversity in the Amazon region, and also opens new perspectives, for the bioprospecting of Actinobacteria as sources of bioactive compounds and therapeutic agents.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e295912
Antibacterial, cytotoxic and antioxidant activities, and identification of bioactive volatile compounds from Streptomyces sp. LV20 isolated from sediments of Lago Verde, Alter do Chão, Amazonia, Brazil
One of the major public health challenges is pathogen resistance to multiple drugs, leading to intensive searches for new antimicrobial agents from natural sources through the exploration of new niches. The objective of this research was to isolate actinobacteria from sediments of Lago Verde (Green Lake) in Alter do Chão, evaluating their antibacterial, cytotoxic, and antioxidant activities, and identifying their bioactive volatile compounds. Identification was carried out through morphological and biochemical evaluation. Antibacterial activity was investigated using the agar disk diffusion method against 17 pathogens of clinical interest. Cytotoxic activity was determined by the percentage inhibition of cell growth in samples of the human colorectal carcinoma cell line HCT116, using a concentration of 10 µg/mL, with results expressed as mean ± SEM (n=2). The determination of antioxidant activity was performed using the DPPH radical scavenging assay. The volatile compound profile of the crude extract was established through gas chromatography-mass spectrometry (GC-MS) analysis. The identification of isolate LV20 shows characteristics of the phylum Actinobacteria, suggestive of the genus Streptomyces. Its antibacterial activity demonstrated action against Staphylococcus epidermidis (17.75 ± 1.25 mm) and Enterococcus faecalis (17.5 ± 0.5 mm), as well as inhibiting the proliferation of the HCT116 tumor cell line by 95.55%. The crude ethyl acetate extract of LV20 showed significant antioxidant activity by the DPPH method, evidenced by an Effective Concentration (EC50) of 890.29 µg/mL. Chromatographic analysis identified bioactive volatile compounds, notably glycerin (28%), tris(2,4-di-tert-butylphenyl) phosphate (22.12%), and benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, octadecyl ester (14.67%), which exhibit pharmacological potential. The novel results demonstrate the biological variability of Streptomyces sp. LV20 as a promising source of bioactive molecules with therapeutic applications, highlighting the importance of Amazonian biodiversity for the bioprospecting of new drugs.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e295912
Open AccessAntibacterial, cytotoxic and antioxidant activities, and identification of bioactive volatile compounds from Streptomyces sp. LV20 isolated from sediments of Lago Verde, Alter do Chão, Amazonia, Brazil
One of the major public health challenges is pathogen resistance to multiple drugs, leading to intensive searches for new antimicrobial agents from natural sources through the exploration of new niches. The objective of this research was to isolate actinobacteria from sediments of Lago Verde (Green Lake) in Alter do Chão, evaluating their antibacterial, cytotoxic, and antioxidant activities, and identifying their bioactive volatile compounds. Identification was carried out through morphological and biochemical evaluation. Antibacterial activity was investigated using the agar disk diffusion method against 17 pathogens of clinical interest. Cytotoxic activity was determined by the percentage inhibition of cell growth in samples of the human colorectal carcinoma cell line HCT116, using a concentration of 10 µg/mL, with results expressed as mean ± SEM (n=2). The determination of antioxidant activity was performed using the DPPH radical scavenging assay. The volatile compound profile of the crude extract was established through gas chromatography-mass spectrometry (GC-MS) analysis. The identification of isolate LV20 shows characteristics of the phylum Actinobacteria, suggestive of the genus Streptomyces. Its antibacterial activity demonstrated action against Staphylococcus epidermidis (17.75 ± 1.25 mm) and Enterococcus faecalis (17.5 ± 0.5 mm), as well as inhibiting the proliferation of the HCT116 tumor cell line by 95.55%. The crude ethyl acetate extract of LV20 showed significant antioxidant activity by the DPPH method, evidenced by an Effective Concentration (EC50) of 890.29 µg/mL. Chromatographic analysis identified bioactive volatile compounds, notably glycerin (28%), tris(2,4-di-tert-butylphenyl) phosphate (22.12%), and benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, octadecyl ester (14.67%), which exhibit pharmacological potential. The novel results demonstrate the biological variability of Streptomyces sp. LV20 as a promising source of bioactive molecules with therapeutic applications, highlighting the importance of Amazonian biodiversity for the bioprospecting of new drugs.
- Open Access
- 1 April 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (4) , e3779
Potencial anticâncer de actinobactérias do gênero Streptomyces Sp.: uma revisão integrativa de literatura
O câncer permanece um dos principais desafios globais de saúde pública, impulsionando a busca por terapias inovadoras e mais efetivas. Nesse cenário, as actinobactérias, especialmente as pertencentes ao gênero Streptomyces, têm se destacado por seu potencial notável na produção de compostos bioativos com propriedades anticancerígenas. Esta revisão integrativa teve como objetivo sintetizar os achados mais relevantes sobre o potencial anticâncer dessas bactérias. A estratégia de busca nas bases de dados Scielo e PubMed, utilizando os descritores "Streptomyces", "Actinobacteria" and "Anticancer", resultou na inclusão de 20 artigos para análise. Os estudos evidenciaram a eficácia dos compostos derivados de actinobactérias contra diversas linhagens de células cancerígenas, incluindo as de câncer de mama, pulmão, cólon e leucemia. Foram empregados métodos variados, como ensaios de citotoxicidade, análises genômicas e docking molecular, para avaliar e compreender os mecanismos de ação desses compostos. Apesar dos resultados promissores obtidos em nível experimental, são necessários estudos adicionais para validar a eficácia e segurança in vivo, bem como desenvolver métodos eficientes para a produção e purificação desses compostos em larga escala. Desafios significativos precisam ser superados, como a transição da pesquisa básica para aplicações clínicas e a conservação da biodiversidade das actinobactérias. Portanto, esta revisão destaca o potencial significativo das actinobactérias na busca por novos agentes anticancerígenos, contribuindo para o avanço científico e oferecendo esperança de terapias mais eficazes contra o câncer. No entanto, é crucial a realização de pesquisas adicionais, bem como a colaboração multidisciplinar, para traduzir esses achados em benefícios tangíveis para a sociedade e o avanço da medicina.
- 1 April 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (4) , e3779
Open AccessPotencial anticâncer de actinobactérias do gênero Streptomyces Sp.: uma revisão integrativa de literatura
O câncer permanece um dos principais desafios globais de saúde pública, impulsionando a busca por terapias inovadoras e mais efetivas. Nesse cenário, as actinobactérias, especialmente as pertencentes ao gênero Streptomyces, têm se destacado por seu potencial notável na produção de compostos bioativos com propriedades anticancerígenas. Esta revisão integrativa teve como objetivo sintetizar os achados mais relevantes sobre o potencial anticâncer dessas bactérias. A estratégia de busca nas bases de dados Scielo e PubMed, utilizando os descritores "Streptomyces", "Actinobacteria" and "Anticancer", resultou na inclusão de 20 artigos para análise. Os estudos evidenciaram a eficácia dos compostos derivados de actinobactérias contra diversas linhagens de células cancerígenas, incluindo as de câncer de mama, pulmão, cólon e leucemia. Foram empregados métodos variados, como ensaios de citotoxicidade, análises genômicas e docking molecular, para avaliar e compreender os mecanismos de ação desses compostos. Apesar dos resultados promissores obtidos em nível experimental, são necessários estudos adicionais para validar a eficácia e segurança in vivo, bem como desenvolver métodos eficientes para a produção e purificação desses compostos em larga escala. Desafios significativos precisam ser superados, como a transição da pesquisa básica para aplicações clínicas e a conservação da biodiversidade das actinobactérias. Portanto, esta revisão destaca o potencial significativo das actinobactérias na busca por novos agentes anticancerígenos, contribuindo para o avanço científico e oferecendo esperança de terapias mais eficazes contra o câncer. No entanto, é crucial a realização de pesquisas adicionais, bem como a colaboração multidisciplinar, para traduzir esses achados em benefícios tangíveis para a sociedade e o avanço da medicina.
- 1 January 2022
- Published by Editora Science
- p. 180-196
RESISTÊNCIA ANTIMICROBIANA: DA CRISE GLOBAL ÀS SOLUÇÕES BIOTECNOLÓGICAS COM Streptomyces
A resistência antimicrobiana impõe uma crise sanitária e econômica global, com aumento de morbimortalidade e pressão sobre sistemas de saúde. Este capítulo aborda produtos naturais microbianos, com ênfase em actinobactérias do gênero Streptomyces, como trajetória promissora para renovar o arsenal terapêutico. Parte-se do problema da queda de eficácia dos antibióticos e do esvaziamento do pipeline industrial, que exigem rotas biotecnológicas capazes de gerar moléculas com novos mecanismos de ação. Objetiva-se integrar evidências sobre a diversidade metabólica de Streptomyces; discutir o papel de agrupamentos de genes biossintéticos (PKS/NRPS e afins) na geração de metabólitos secundários; e apresentar estratégias de descoberta e ativação de clusters. Adota-se revisão narrativa da literatura recente em bioprospecção, mineração genômica e expressão heteróloga. A síntese indica que Streptomyces responde por parcela substancial dos produtos naturais bioativos conhecidos, com dezenas de BGCs por genoma, muitos silenciosos. Abordagens como mineração in silico, co-cultivo, edição de genomas e modulação ambiental têm expandido a ativação de compostos com atividades antibacterianas, antifúngicas e antitumorais. Conclui-se que actinobactérias, especialmente Streptomyces, constituem um eixo sustentável para a inovação antimicrobiana, demandando integração entre microbiologia, genômica e engenharia de processos para avançar em validação pré-clínica/clínica e escalabilidade.
- 1 January 2022
- Published by Editora Science
- p. 180-196
RESISTÊNCIA ANTIMICROBIANA: DA CRISE GLOBAL ÀS SOLUÇÕES BIOTECNOLÓGICAS COM Streptomyces
A resistência antimicrobiana impõe uma crise sanitária e econômica global, com aumento de morbimortalidade e pressão sobre sistemas de saúde. Este capítulo aborda produtos naturais microbianos, com ênfase em actinobactérias do gênero Streptomyces, como trajetória promissora para renovar o arsenal terapêutico. Parte-se do problema da queda de eficácia dos antibióticos e do esvaziamento do pipeline industrial, que exigem rotas biotecnológicas capazes de gerar moléculas com novos mecanismos de ação. Objetiva-se integrar evidências sobre a diversidade metabólica de Streptomyces; discutir o papel de agrupamentos de genes biossintéticos (PKS/NRPS e afins) na geração de metabólitos secundários; e apresentar estratégias de descoberta e ativação de clusters. Adota-se revisão narrativa da literatura recente em bioprospecção, mineração genômica e expressão heteróloga. A síntese indica que Streptomyces responde por parcela substancial dos produtos naturais bioativos conhecidos, com dezenas de BGCs por genoma, muitos silenciosos. Abordagens como mineração in silico, co-cultivo, edição de genomas e modulação ambiental têm expandido a ativação de compostos com atividades antibacterianas, antifúngicas e antitumorais. Conclui-se que actinobactérias, especialmente Streptomyces, constituem um eixo sustentável para a inovação antimicrobiana, demandando integração entre microbiologia, genômica e engenharia de processos para avançar em validação pré-clínica/clínica e escalabilidade.
- 1 January 2022
- Published by Editora Science
- p. 197-210
O ARSENAL BIOATIVO DE Streptomyces: DE COMPOSTOS HISTÓRICOS A NOVAS DESCOBERTAS
A resistência antimicrobiana (RAM) representa uma crise de saúde pública global, impulsionada pelo surgimento de patógenos multirresistentes e pela estagnação na descoberta de novos antibióticos, ameaçando a eficácia de tratamentos e a segurança de procedimentos médicos. Neste cenário, o gênero bacteriano Streptomyces ressurge como uma fonte estratégica para a renovação do arsenal terapêutico. Este capítulo, elaborado como uma revisão narrativa, sintetiza a importância histórica e o potencial futuro de Streptomyces na busca por novos compostos bioativos. Aborda-se a magnitude da RAM, exemplificada por microrganismos do grupo ESKAPE, e a drástica redução no desenvolvimento de novas classes de antimicrobianos nas últimas décadas. Historicamente, Streptomyces é responsável pela produção de aproximadamente dois terços dos antibióticos conhecidos, como a estreptomicina e as tetraciclinas. A análise de seus genomas extensos revela um vasto repertório de agrupamentos de genes biossintéticos (BGCs), muitos dos quais permanecem silenciosos ou "crípticos" em condições laboratoriais padrão. A ativação desses BGCs inexplorados, por meio de abordagens que integram genômica e biotecnologia, constitui uma das fronteiras mais promissoras para a identificação de moléculas com mecanismos de ação inovadores. Conclui-se que a exploração sistemática do potencial genético de Streptomyces é fundamental para o desenvolvimento de uma nova geração de antimicrobianos capazes de combater as infecções causadas por patógenos resistentes, oferecendo uma resposta biotecnológica à crescente ameaça da RAM.
- 1 January 2022
- Published by Editora Science
- p. 197-210
O ARSENAL BIOATIVO DE Streptomyces: DE COMPOSTOS HISTÓRICOS A NOVAS DESCOBERTAS
A resistência antimicrobiana (RAM) representa uma crise de saúde pública global, impulsionada pelo surgimento de patógenos multirresistentes e pela estagnação na descoberta de novos antibióticos, ameaçando a eficácia de tratamentos e a segurança de procedimentos médicos. Neste cenário, o gênero bacteriano Streptomyces ressurge como uma fonte estratégica para a renovação do arsenal terapêutico. Este capítulo, elaborado como uma revisão narrativa, sintetiza a importância histórica e o potencial futuro de Streptomyces na busca por novos compostos bioativos. Aborda-se a magnitude da RAM, exemplificada por microrganismos do grupo ESKAPE, e a drástica redução no desenvolvimento de novas classes de antimicrobianos nas últimas décadas. Historicamente, Streptomyces é responsável pela produção de aproximadamente dois terços dos antibióticos conhecidos, como a estreptomicina e as tetraciclinas. A análise de seus genomas extensos revela um vasto repertório de agrupamentos de genes biossintéticos (BGCs), muitos dos quais permanecem silenciosos ou "crípticos" em condições laboratoriais padrão. A ativação desses BGCs inexplorados, por meio de abordagens que integram genômica e biotecnologia, constitui uma das fronteiras mais promissoras para a identificação de moléculas com mecanismos de ação inovadores. Conclui-se que a exploração sistemática do potencial genético de Streptomyces é fundamental para o desenvolvimento de uma nova geração de antimicrobianos capazes de combater as infecções causadas por patógenos resistentes, oferecendo uma resposta biotecnológica à crescente ameaça da RAM.